Skip to content

Multicenter, Prospective, Comparative, Randomized, Single blind, Superior, Pivotal study to evaluate the clinical effectiveness and safety of respiratory rehabilitation software ‘Redpill Breath’ compared to the manual rehabilitation management for those needs respiratory rehabilitation(COPD, Asthma, Lung Cancer, etc.)

Multicenter, Prospective, Comparative, Randomized, Single blind, Superior, Pivotal study to evaluate the clinical effectiveness and safety of respiratory rehabilitation software ‘Redpill Breath’ compared to the manual rehabilitation management for those needs respiratory rehabilitation(COPD, Asthma, Lung Cancer, etc.)

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CRIS
Registry ID
KCT0006694
Enrollment
100
Registered
2021-11-01
Start date
2022-01-20
Completion date
Unknown
Last updated
2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device, Behavioral : 1. Test group: patients who use the software as the medical device for respiratory Rehabilitation at home. the medical device for the clinical trial 1) REDFILL SUMTOM/(LS-

Sponsors

Lifesemantics
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Years of age: (Adults) 19 to 80 2. If there is a patient who have difficulty in respiratory symptoms and routine with the criteria as below 1)mMRC(modified Medical Research Council Dyspnea Scale) 1 point at least 2)In accordance with Pulmonary function test(PFT/LET/EEG) patients was examined, if there is in one of the following cases as below [a lung cancer patient] (FVC or FEV1 < 80%), [No lung cancer patient] (Post-bronchodilator FEV1/FVC < 0.7) and (Post-bronchodilator FEV1 < 80%) 3. a patient with an Android smartphone (OS 8.0 or higher, internal memory (HDD) of 32GB or higher) or iPhone (iOS 13.0 or higher, internal memory (HDD of 32GB or higher) 4. a patient who can use effectively smartphone and mobile software 5. a patient who brings their smartphone for a walking test during 12 weeks of the clinical trial. 6. a patient who makes the decision voluntarily for participating in the clinical trial and to write their signature to the consent of subject's explanation. 7. a patient who complies with the clinical protocol

Exclusion criteria

Exclusion criteria: 1. a person who has respiratory distress syndrome, caused by a kind of Neuromuscular disease, Spinal cord injury, Thoracic deformation, etc. 2. a person who participate in respiratory rehabilitation treatment within a year of the screening date 3. a person who undergoes respiratory-related symptoms deteriorate within 2 weeks of the screening date to the point where they need additional antibiotics or steroids 4. a person who has an unstable cardiovascular disease (unstable angina pectoris, Acute myocardial infarction, severe coarctation of aorta, etc.) 5. a pulmonary arterial hypertension patient 6. a person prescribed physical(e.g. lower-leg joint surgery, neurological limitation) or cognitive factors(e.g. psychical disorder) 7. Pregnant or lactating women 8. a person who is unable to read text and tough to communicate 9. a person who has participated in other clinical trials within 90 days of the screening date or participating in other clinical trials. 10. a person who is determined to inappropriate to perform this study according to clinical research associate’s opinion(e.g if someone has a bearing on the result of the clinical trial ethically or clinically)

Design outcomes

Primary

MeasureTime frame
The 6-minute walking distance (6 minute walking distance, 6MWD) change amount (m)2 at 12 weeks after respiratory rehabilitation compared to the base point.

Secondary

MeasureTime frame
The 6-minute walking distance (6 minute walking distance, 6MWD) at 8 weeks after respiratory rehabilitation compared to the base point (m) change.;The amount of change in the mMRC (modified medical research council Dyspnea scale) score at 8 and 12 weeks after respiratory rehabilitation compared to the base point (point);The amount of change in the SGRQ (Structures Respiratory Questionnaire) score at 8 and 12 weeks after respiratory rehabilitation compared to the base point (point);The amount of change in the Hospital Anxiety and Depression Scale (HADS) at 8 and 12 weeks after respiratory rehabilitation compared to the base point (point);The amount of change in the average number of daily steps per week during the respiratory rehabilitation treatment period (number of times);The amount of change in the use of medical support (number of hospitalizations, number of days of hospitalization, number of days of emergency room visits) (number of times);Abnormal case (safety evaluation variable);Patient Global Assessment (PGA) evaluation at 12 weeks after respiratory rehabilitation treatment.;Evaluation of the number of treatments during the respiratory rehabilitation treatment period (number of times)

Countries

Korea, Republic of

Contacts

Public ContactSumin Han

Lifesemantics

sm.han@lifesemantics.kr+82-2-1661-2858

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026